CI The Cigna Group

Cigna Corporation provides insurance and related products and services in the United States. Its Evernorth segment provides a range of coordinated and point solution health services, including pharmacy, benefits management, care, and intelligence solutions to health plans, employers, government organizations, and health care providers. The company's U.S. Medical segment offers commercial products and services, including medical, pharmacy, behavioral health, dental, vision, health advocacy programs, and other products and services for insured and self-insured customers; Medicare Advantage, Medicare Supplement, and Medicare Part D plans for seniors, as well as Medicaid plans; and individual health insurance plans to on and off the public exchanges. Its International Markets segment offers health coverage, hospitalization, dental, critical illness, personal accident, term life, medical cost containment, and variable universal life products, as well as health care benefits to mobile employees of multinational organizations. The company distributes its products and services through insurance brokers and consultants; directly to employers, unions and other groups, or individuals; and private and public exchanges. The company was founded in 1792 and is headquartered in Bloomfield, Connecticut.

Recent Analyst Ratings for The Cigna Group

Date	Price Target	Rating	Analyst
2/6/2025	$323.00	Outperform → Mkt Perform	Bernstein
6/26/2024	$400.00	Overweight	Piper Sandler
5/30/2024	$388.00	Outperform	Robert W. Baird
3/6/2024	$393.00	Overweight	Barclays
2/5/2024	$334.00 → $372.00	Neutral → Overweight	Cantor Fitzgerald
2/5/2024	$327.00 → $354.00	Sector Perform → Outperform	RBC Capital Mkts
2/1/2024	$355.00 → $370.00	Hold → Buy	Deutsche Bank
1/4/2024	$330.00 → $372.00	Mkt Perform → Outperform	Bernstein
12/11/2023	$335.00 → $341.00	Hold → Buy	Jefferies
8/18/2023		Buy → Hold	Edward Jones

See more ratings

The Cigna Group

Peers

Recent Analyst Ratings for The Cigna Group

The Cigna Group Insider Trading

Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

Director Hennigan Michael J was granted 568 shares (SEC Form 4)

SEC Form 3 filed by new insider Hennigan Michael J

SEC Form 4 filed by Director Kurian George

Director Wiseman Eric C was granted 638 shares, increasing direct ownership by 3% to 23,158 units (SEC Form 4)

Director Ross Kimberly A. was granted 638 shares, increasing direct ownership by 16% to 4,512 units (SEC Form 4)

Director Zarcone Donna F was granted 638 shares, increasing direct ownership by 2% to 26,735 units (SEC Form 4)

Director Ozuah Philip was granted 638 shares, increasing direct ownership by 55% to 1,801 units (SEC Form 4)

Director Kurian George was granted 638 shares, increasing direct ownership by 20% to 3,778 units (SEC Form 4)

Director Mcclellan Mark B. was granted 638 shares, increasing direct ownership by 12% to 6,109 units (SEC Form 4)

Director Foss Eric J was granted 638 shares, increasing direct ownership by 2% to 35,914 units (SEC Form 4)